跳至主要内容
临床试验/NCT01290796
NCT01290796已完成不适用

Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)

C. R. Bard12 个研究点 分布在 1 个国家目标入组 153 人开始时间: 2011年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
153
试验地点
12
主要终点
Percentage of Patients Free of Stress Urinary Incontinence

研究概览

简要总结

The purpose of this study is to assess the overall effectiveness of the Ajust Adjustable Single-Incision Sling in the surgical treatment of female stress urinary incontinence.

详细描述

Urinary incontinence (UI), or the complaint of any involuntary loss of urine, ranges in severity from the occasional leaking urine during actions resulting in increased abdominal pressure (coughing, sneezing, laughing, exercise, etc.) to sudden, unpredictable strong urges to void. Female stress urinary incontinence (SUI) is attributed to a weakening of the pelvic floor muscles.

A recent review of literature describing the prevalence of UI calculated the median prevalence of female UI to be 27.6% (4.8-58.4%), with the prevalence of significant incontinence increasing with age. The prevalent cause of UI was further categorized into stress (50%), mixed (32%) and urge (14%).

Nonsurgical treatment of female SUI has traditionally been limited to alpha-adrenergic agonists and estrogens, pelvic floor exercises, biofeedback, electrical stimulation and behavior modification1. Options for surgical treatment consists of periurethral injections of bulking agents, transvaginal suspensions, retropubic suspensions, slings and sphincter prostheses.

The Ajust™ Adjustable Single-Incision Sling is a fully adjustable single-incision sling that anchors in the transobturator membranes, anatomically sufficient spaces for support of the urethra.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female, age at least 18 years
  • Have signed an Informed Consent Form
  • Has been diagnosed with stress urinary incontinence as documented by: a minimum 30-degree urethral deflection, considered to be a candidate for transobturator repair by consulting surgeon (investigator), has a positive CST
  • Desires surgical correction of SUI using the Ajust™ Adjustable Single-Incision Sling

排除标准

  • Patient is actively participating in any other genitourinary clinical trial of an experimental drug or device
  • Patient is known to be pregnant or desiring future childbearing
  • Patient has a known urinary tract infection, or known infection in the operative field at the time of device implantation
  • Patient is unable to have their anticoagulation therapy suspended for the completion of the surgical procedure
  • Patient requires concurrent correction of pelvic organ prolapse
  • Patient has a history of previous sling procedure
  • Patient has known history of detrusor overactivity demonstrated by urodynamics
  • Patient has known urinary retention
  • Patient has a current genitourinary fistula or urinary diverticulum
  • Patient has a prior history of pelvic radiation
  • Patient has a MESA urge symptom score (% of total possible urge score) that is greater than their MESA stress symptom score (% of total possible stress score)
  • Any condition in the opinion of the Investigator that would preclude the use of the Ajust™ Adjustable Single-Incision Sling, or preclude the subject from completing the follow-up requirements

结局指标

主要结局

Percentage of Patients Free of Stress Urinary Incontinence

时间窗: 12-months post surgical procedure

Percentage of patients who are free of stress urinary incontinence, as assessed by a negative (-) Cough Stress Test (CST) and no surgical retreatment, at the 12 month study visit.

Percentage of Subjects Who Showed Improvement in Self-reported SUI Symptoms at 12 Months

时间窗: 12-months post procedure

Improvement was defined as a 25-point decrease (improvement) in Urinary Distress Inventory (UDI-6) score (Range: 0 - 100).

次要结局

  • Operative, Perioperative and Long-Term Complications During Operative Procedure(1 day)
  • Operative, Perioperative and Long-Term Complications Perioperatively(1-15 days)
  • Change in Incontinent Impact Questionnaire at 36 Months(0-36 months)
  • Percentage of Patients With Impression of Improvement With Procedure at 12 Months(0-12 Months)
  • Operative, Perioperative and Long-term Complications Through 36 Months(Day 15 through 36-months post procedure)
  • Change in Post-operative Pain(0-7 days)
  • Change in Incontinent Impact Questionnaire at 12 Months(0-12 months)
  • Percentage of Subjects Who Showed Improvement in Self-reported SUI Symptoms at 36 Months(0-36 Months)
  • Percentage of Patients With Impression of Improvement With Procedure at 36 Months(0-36 Months)

研究者

发起方
C. R. Bard
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验